UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000001738
Receipt No. R000002091
Scientific Title Phase II study of gefitinib therapy inserted by chemotherapy as first line treatment for advanced non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutation
Date of disclosure of the study information 2009/03/01
Last modified on 2013/09/05 15:16:46

No. Disposal Last modified on Item of update
1 Insert 2009/02/27 10:57:21
2 Update 2012/03/27 17:45:22 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2012/03/27 17:46:04 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2013/09/05 15:13:25 Email
5 Update 2013/09/05 15:16:46 Recruitment status
Date analysis concluded
Publication of results

Contact us.